Inhibition of Different Lassa Virus Strains by Alpha and Gamma Interferons and Comparison with a Less Pathogenic Arenavirus

Journal of Virology

Volumn 78, Issue 6, 2004, Pages 3162-3169

  Asper, Marcel ^a   Sternsdorf, Thomas ^b   Hass, Meike ^a   Drosten, Christian ^a   Rhode, Antje ^a   Schmitz, Herbert ^a   Günther, Stephan ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN SP100; RECOMBINANT ALPHA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARENAVIRUS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LASSA FEVER; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VERO CELL; VIROGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIGENS, NUCLEAR; ANTIVIRAL AGENTS; AUTOANTIGENS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; LASSA FEVER; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; SEVERITY OF ILLNESS INDEX; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS; VERO CELLS; VIRUS REPLICATION;

EID: 1542347736     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.6.3162-3169.2004     Document Type: Article

References (50)

1. Armstrong, C., and R. D. Líllie. 1934. Experimental lymphocytic choriomeningitis of monkeys and mice produced by a virus encountered in studies of the 1933 St. Louis encephalitis epidemic. Public Health Rep. 49:1019-1027.
2. Asper, M., P. Hofmann, C. Osmann, J. Funk, C. Metzger, M. Bruns, F. J. Kaup, H. Schmítz, and S. Günther. 2001. First outbreak of callitrichid hepatitis in Germany: genetic characterization of the causative lymphocytic choriomeningitis virus strains. Virology 284:203-213.
3. Baillíe, J., D. A. Sahlender, and J. H. Sínclair. 2003. Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor. J. Virol. 77:7007-7016.
4. Battegay, M., S. Cooper, A. Althage, J. Banziger, H. Hengartner, and R. M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33:191-198.
5. Biermer, M., R. Puro, and R. J. Schneíder. 2003. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid integrity through activation of NF-κB. J. Virol. 77:4033-4042.
6. Blondel, D., T. Regad, N. Poisson, B. Pavie, F. Harper, P. P. Pandolfi, H. De The, and M. K. Chelbí-Alix. 2002. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21:7957-7970.
7. Bonilla, W. V., D. D. Pinschewer, P. Klenerman, V. Rousson, M. Gaboli, P. P. Pandolfi, R. M. Zinkernagel, M. S. Salvato, and H. Hengartner. 2002. Effects of promyelocytic leukemia protein on virus-host balance. J. Virol. 76:3810-3818.
8. Boom, R., C. J. Sol, M. M. Salimans, C. L. Jansen, P. M. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
9. Borden, K. L., E. J. Campbell Dwyer, and M. S. Salvato. 1998. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J. Virol. 72:758-766.
10. Bose, S., N. Kar, R. Maitra, J. A. DiDonato, and A. K. Banerjee. 2003. Temporal activation of NF-κB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses. Proc. Natl. Acad. Sci. USA 100:10890-10895.
11. Bowen, M. D., P. E. Rollin, T. G. Ksiazek, H. L Hustad, D. G. Bausch, A. H. Demby, M. D. Bajani, C. J. Peters, and S. T. Nichol. 2000. Genetic diversity among Lassa virus strains. J. Virol. 74:6992-7004.
12. Bray, M., J. L. Raymond, T. Geisbert, and R. O. Baker. 2002. 3-Deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice. Antivir. Res. 55:151-159.
13. Carrigan, D. R., and K. K. Knox. 1990. Identification of interferon-resistant subpopulations in several strains of measles virus: positive selection by growth of the virus in brain tissue. J. Virol. 64:1606-1615.
14. Chee, A. V., P. Lopez, P. P. Pandolfi, and B. Roizman. 2003. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol. 77:7101-7105.
15. Chelbi-Alix, M. K., L. Pelicano, F. Quignon, M. H. Koken, L. Venturini, M. Stadler, J. Pavlovic, L. Degos, and H. de The. 1995. Induction of the PML protein by interferons in normal and APL cells. Leukemia 9 2027-2033.
16. Demby, A. H., J. Chamberlain, D. W. Brown, and C. S. Clegg. 1994. Early diagnosis of Lassa fever by reverse transcription-PCR. J. Clin. Microbiol. 32:2898-2903.
17. Djavani, M., J. Rodas, I. S. Lukashevich, D. Horejsh, P. P. Pandolfi, K. L. Borden, and M. S. Salvato. 2001. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J. Virol. 75:6204-6208.
18. Emeny, J. M., and M. J. Morgan. 1979. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J. Gen. Virol. 43:247-252.
19. Friedman, J. M., and M. S. Horwitz. 2002. Inhibition of tumor necrosis factor alpha-induced NF-KB activation by the adenovirus E3-10.4/14.5K complex. J. Virol. 76:5515-5521.
20. Geimonen, E., S. Neff, T. Raymond, S. S. Kocer, I. N. Gavrilovskaya, and E. R. Mackow. 2002. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl. Acad. Sci. USA 99: 13837-13842.
21. Grötzinger, T., K. Jensen, and H. Will. 1996. The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J. Biol. Chem. 271:25253-25260.
22. Grötzinger, T., T. Sternsdorf, K. Jensen, and H. Will. 1996. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur. J. Biochem. 238: 554-560.
23. Guidotti, L. G., P. Borrow, A. Brown, H. McClary, R. Koch, and F. V. Chisarí. 1999. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J. Exp. Med. 189:1555-1564.
24. Günther, S., P. Emmerich, T. Laue, O. Kühle, M. Asper, A. Jung, T. Grewing, J. ter Meulen, and H. Schmitz. 2000. Imported Lassa fever in Germany: molecular characterization of a new Lassa virus strain. Emerg. Infect. Dis. 6:466-476.
25. Günther, S., B. Weisner, A. Roth, T. Grewing, M. Asper, C. Drosten, P. Emmerich, J. Petersen, M. Wilczek, and H. Schmitz. 2001. Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J. Infect. Dis. 184:345-349.
26. Hufert, F. T., W. Ludke, and H. Schmitz. 1989. Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies. Arch. Virol. 106:201-212.
27. Jahrling, P. B., J. D. Frame, S. B. Smith, and M. H. Monson. 1985. Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Trans. R. Soc. Trop. Med. Hyg. 79:374-379.
28. Jensen, K., C. Shíels, and P. S. Freemont. 2001. PML protein isoforms and the RBCC/TRIM motif. Oncogene 20:7223-7233.
29. Khaiboullina, S. F., D. M. Netski, P. Krumpe, and S. C. St Jeor. 2000. Effects of tumor necrosis factor alpha on Sin Nombre virus infection in vitro. J. Virol. 74:11966-11971.
30. Leyssen, P., C. Drosten, M. Paning, N. Charlier, J. Paeshuyse, E. De Clereq, and J. Neyts. 2003. Interferons, interferon inducers, and interferon-ribavirin in treatment of flavivirus-induced encephalitis in mice. Antimicrob. Agents Chemother. 47:777-782.
31. Lopez, P., R. J. Jacob, and B. Roizman. 2002. Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins. J. Virol. 76:9355-9367.
32. Lu, Y., M. Wambach, M. G. Katze, and K. M. Krug. 1995. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214:222-228.
33. Lucin, P., S. Jonjic, M. Messerle, B. Polic, H. Hengel, and U. H. Koszinowski. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J. Gen. Virol. 75:101-110.
34. McCormick, J. B., I. J. King, P. A. Webb, K. M. Johnson, R. O'Sullivan, E. S. Smith, S. Trippel, and T. C. Tong. 1987. A case-control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis. 155:445-455.
35. McCormick, J. B., I. J. King, P. A. Webb, C. L. Scribner, R. B. Craven, K. M. Johnson, L. H. Elliott, and R. Belmont-Williams. 1986. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314:20-26.
36. McCormick, J. B., D. H. Walker, I. J. King, P. A. Webb, L. H. Elliott, S. G. Whitfield, and K. M. Johnson. 1986. Lassa virus hepatitis: a study of fatal Lassa fever in humans. Am. J. Trop. Med. Hyg. 35:401-407.
37. Moskophidis, D., M. Battegay, M. A. Bruendler, E. Laine, I. Gresser, and R. M. Zinkernagel. 1994. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J. Virol. 68:1951-1955.
38. Ou, R., S. Zhou, L Huang, and D. Moskophidis. 2001. Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 75:8407-8423.
39. Peters, C. J., C. T. Liu, G. W. Anderson, J. C. Morrill, and P. B. Jahrling. 1989. Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev. Infect. Dis. 11(Suppl. 4):S743-S749.
40. Powell, P. P., L. K. Dixon, and R. M. Parkhouse. 1996. An IκB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J. Virol. 70:8527-8533.
41. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
42. Schmitz, H., B. Köhler, T. Laue, C. Drosten, P. J. Veldkamp, S. Günther, P. Emmerich, H. P. Geisen, K. Fleischer, M. F. Beersma, and A. Hoerauf. 2002. Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect. 4:43-50.
43. Scott, T. F. M., and T. M. Rivers. 1936. Meningitis in man caused by a filterable virus. I. Two cases and the method of obtaining a virus from their spinal fluids. J. Exp. Med. 63:397-414.
44. Seo, S. H., E. Hoffmann, and R. G. Webster. 2002. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med. 8:950-954.
45. Seo, S. H., and R. G. Webster. 2002. Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J. Virol. 76:1071-1076.
46. Spotts, D. R., R. M. Reich, M. A. Kalkhan, R. M. Kinney, and J. T. Roehrig. 1998. Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5′ noncoding region and glycoproteins. J. Virol. 72:10286-10291.
47. Sternsdorf, T., H. H. Guldner, C. Szostecki, T. Grötzinger, and H. Will. 1995. Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand. J. Immunol. 42:257-268.
48. Sternsdorf, T., K. Jensen, and H. Will. 1997. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139:1621-1634.
49. Su, Y. H., J. E. Oakes, and R. N. Lausch. 1990. Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon. J. Virol. 64:2187-2192.
50. Walker, D. H., J. B. McCormick, K. M. Johnson, P. A. Webb, G. Komba-Kono, L. H. Elliott, and J. J. Gardner. 1982. Pathologic and virologic study of fatal Lassa fever in man. Am. J. Pathol. 107:349-356.